Robert Anolik
St. Joseph's Hospital and Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert Anolik.
Archives of Dermatology | 2012
Jeremy A. Brauer; Kavitha K. Reddy; Robert Anolik; Elliot Weiss; Julie K. Karen; Elizabeth K. Hale; Lori Brightman; Leonard J. Bernstein; Roy G. Geronemus
BACKGROUND While the understanding and technology of laser tattoo removal has advanced much over the last 5 decades, treatments and results remain far from perfect. With currently available devices, treatment courses are often painful and prolonged with mixed results. We describe the successful and rapid treatment of 12 tattoos containing blue and/or green pigment with a novel, picosecond, 755-nm alexandrite laser. OBSERVATIONS All previously untreated multicolored tattoos as well as tattoos recalcitrant to treatment demonstrated at least 75% clearance of blue and green pigment after 1 or 2 treatments with a novel, picosecond, 755-nm alexandrite laser. More than two-thirds of these tattoos approached closer to 100% clearance. CONCLUSIONS While additional future studies are needed, we believe that this new technology is more effective in targeting blue and green pigment, resulting in expedited clearance with less collateral injury to surrounding tissue.
Dermatologic Surgery | 2013
Kavitha K. Reddy; Francine Blei; Jeremy A. Brauer; Milton Waner; Robert Anolik; Leonard J. Bernstein; Lori Brightman; Elizabeth K. Hale; Julie K. Karen; Elliot Weiss; Roy G. Geronemus
BACKGROUND Infantile hemangioma (IH) clearance may be slow or incomplete in response to pulsed dye laser (PDL) or propranolol alone. OBJECTIVES To evaluate whether IH treated with PDL and propranolol displayed more rapid and complete clearance than IH treated with propranolol alone. MATERIALS AND METHODS Retrospective review of facial‐segmental IH treated with propranolol and PDL and controls treated with propranolol was conducted. Blinded physicians used patient photographs to select clearance level and the earliest date of near‐complete clearance. Days of propranolol, PDL sessions, and propranolol dose, each until date of near‐complete clearance; total days of propranolol; and total propranolol dose were recorded. RESULTS Infantile hemangiomas treated concurrently with propranolol and PDL achieved complete clearance (6/12) more often than IH treated with propranolol followed by PDL (2/5) or IH treated with propranolol alone (1/8; difference in clearance scores p = .01) and achieved near‐complete clearance after fewer days of propranolol (mean 92 days for concurrent propranolol and PDL vs 288 days for propranolol; p < .001). Cumulative propranolol dose until near‐complete clearance was lowest in the concurrent propranolol and PDL group (149.16 vs 401.25 mg/kg for propranolol; p < .001). CONCLUSION Facial‐segmental IH treated with propranolol and PDL displayed morerapid and complete clearance and required a lower cumulative propranolol dose to achieve near‐complete clearance.
Archives of Dermatology | 2012
Lori Brightman; Jeremy A. Brauer; Vitaly Terushkin; Christopher M. Hunzeker; Kavitha K. Reddy; Elliot Weiss; Julie K. Karen; Elizabeth K. Hale; Robert Anolik; Leonard J. Bernstein; Roy G. Geronemus
BACKGROUND Given the natural tendency for 15% to 40% of infantile hemangiomas to spontaneously involute over time, much debate surrounds the issue of treatment. Until recently, effective therapies to improve the appearance of residual textural skin changes in these patients were lacking. We suggest the use of ablative fractional resurfacing for the treatment of textural skin changes resulting from involuted hemangiomas. OBSERVATIONS All patients treated with an ablative fractional carbon dioxide laser experienced considerable flattening of the fibrofatty residual tissue, with at least 50% to 75% improvement in color, texture, and overall appearance. CONCLUSION While additional future studies are needed, we believe that ablative fractional resurfacing should be considered for the treatment of textural skin changes associated with involuted infantile hemangiomas.
Archives of Dermatology | 2012
Kavitha K. Reddy; Jeremy A. Brauer; Robert Anolik; Leonard J. Bernstein; Lori Brightman; Elizabeth K. Hale; Julie K. Karen; Elliot Weiss; Roy G. Geronemus
BACKGROUND Injection of calcium hydroxylapatite filler may result in nodule formation owing to superficial placement of the filler. Calcium hydroxylapatite nodules are difficult to reverse. Previously reported therapeutic options are limited and include intralesional triamcinolone, massage, needling, and excision, each with inconsistent results or potential for scarring. OBSERVATION We have observed complete resolution of calcium hydroxylapatite nodules after a single treatment with fractional carbon dioxide laser. CONCLUSIONS A single session of fractional carbon dioxide laser treatment may resolve selected cases of calcium hydroxylapatite nodules. The mechanism of action may involve conversion of the product into tricalcium phosphates which dissolve readily. This novel therapeutic technique may enhance treatment options for a difficult clinical problem.
Lasers in Surgery and Medicine | 2013
Kavitha K. Reddy; Jeremy A. Brauer; Robert Anolik; Leonard J. Bernstein; Lori Brightman; Elizabeth K. Hale; Julie K. Karen; Elliot Weiss; Roy G. Geronemus
Laser tattoo removal using multiple passes per session, with each pass delivered after spontaneous resolution of whitening, improves tattoo fading in a 60‐minute treatment time. Our objective was to evaluate the safety and efficacy of topical perfluorodecalin (PFD) in facilitating rapid effective multiple‐pass tattoo removal.
Journal of The American Academy of Dermatology | 2012
Robert Anolik; Tracey Newlove; Elliot Weiss; Lori Brightman; Elizabeth K. Hale; Julie K. Karen; Leonard J. Bernstein; Roy G. Geronemus
BACKGROUND Port-wine stains (PWS) affect 0.3% to 0.5% of newborns and pulsed dye laser (PDL) remains the treatment of choice. Optimal treatment intervals have not been established. OBJECTIVE We sought to validate the optimal treatment intervals for the management of facial PWS with PDL. METHODS In all, 24 infants with facial PWS who received at least 5 treatments with the PDL at 2-, 3-, and 4-week intervals at a private laser and skin surgery center from 2009 to 2010 were identified by a retrospective chart review. Safety and efficacy were compared by blinded investigators. RESULTS Side effects were equivalent in all interval groups and included only expected short-term erythema, edema, purpura, and mild postinflammatory hyperpigmentation. No patient developed hypopigmentation, scarring, or infection. All interval groups showed 50% to 100% clearance of their PWS after 5 treatments. Complete or near-complete clearance was seen in 6 of 8 (75%) and 7 of 8 (87.5%) patients in the 2- and 3-week interval groups, respectively, as compared with 3 of 8 (37.5%) patients in the 4-week interval group. LIMITATIONS This was a retrospective chart review from a single institution. Long-term side effects and recurrence rates were not assessed. CONCLUSION We conclude that PDL treatments at 2-, 3-, and 4-week intervals are effective for the management of facial PWS in infants with minimal short-term side effects. Shorter treatment intervals may allow for relatively more rapid and more effective treatment.
Dermatology Online Journal | 2008
Robert Anolik; Christine Liang; Nadia Wang; Karla Rosenman; Miriam Keltz Pomeranz; Edwin K Joe
A 59-year-old man presented with a well-demarcated, tender ulcer at the base of the penile shaft that had been present for approximately five years. The ulcer had been responsive neither to topical antibacterials, antifungals, and glucocorticoids nor to oral acyclovir. A biopsy specimen showed an intra-epidermal neoplasm consistent with extramammary Paget disease (EMPD) based on light microscopy and immunohistochemistry. Patients with EMPD require extensive medical evaluation because of its association with adnexal carcinoma and visceral malignant conditions. Evaluation should include a full body skin and lymph node examination, colonscopy, cystoscopy, and sex-specific studies including pelvic and breast examinations, with imaging for women and prostate examination with prostate specific antigen levels for men. Close monitoring after treatment is important because of the recognized risk of recurrence and malignant conditions.
Dermatologic Surgery | 2017
Anthony M. Rossi; Joseph Eviatar; Jeremy B. Green; Robert Anolik; Michael Eidelman; Terrence C. Keaney; Vic Narurkar; Derek Jones; Julia Kolodziejczyk; Adrienne Drinkwater; Conor J. Gallagher
BACKGROUND Men are a growing patient population in aesthetic medicine and are increasingly seeking minimally invasive cosmetic procedures. OBJECTIVE To examine differences in the timing of facial aging and in the prevalence of preventive facial aging behaviors in men by race/ethnicity. METHODS Men aged 18 to 75 years in the United States, Canada, United Kingdom, and Australia rated their features using photonumeric rating scales for 10 facial aging characteristics. Impact of race/ethnicity (Caucasian, black, Asian, Hispanic) on severity of each feature was assessed. Subjects also reported the frequency of dermatologic facial product use. RESULTS The study included 819 men. Glabellar lines, crows feet lines, and nasolabial folds showed the greatest change with age. Caucasian men reported more severe signs of aging and earlier onset, by 10 to 20 years, compared with Asian, Hispanic, and, particularly, black men. In all racial/ethnic groups, most men did not regularly engage in basic, antiaging preventive behaviors, such as use of sunscreen. CONCLUSION Findings from this study conducted in a globally diverse sample may guide clinical discussions with men about the prevention and treatment of signs of facial aging, to help men of all races/ethnicities achieve their desired aesthetic outcomes.
Archive | 2012
Robert Anolik; Roy G. Geronemus
When Albert Einstein first developed the concept of laser radiation in The Quantum Theory of Radiation, none could have predicted all its future roles in the applied sciences [1]. Since that time, physicians have used lasers along with other components of the electromagnetic spectrum in a variety of medical and cosmetic applications. In part because of accessibility, many of these developments have involved the skin and eyes.
Dermatology Online Journal | 2010
Robert Anolik; Rajni V. Mandal; Andrew G. Franks